Twin-Blade of a novel IMPDH Inhibitor FF-10501
Abstract
Since chemoresistance hampers a remission and results in a relapse of the patients with cancers, new approaches that do not rely on the existing strategies are needed. FF-10501 is a novel inhibitor for inosine monophosphate hydrogenase (IMPDH), a promising therapeutic target for cancer because IMPDH2 has been reported to be overexpressed in a variety of cancers. We previously reported the mechanism of cell death induced by FF-10501 using hematological malignant cell lines. FF-10501 induces not only apoptosis in a caspase-dependent manner but also induced non-apoptotic cell death. FF-10501 has the potential to be therapeutic drug for cancer and to overcome chemoresistance arise from apoptosis resistance.
Select your language of interest to view the total content in your interested language
Share This Article
Open 91桃色 Journals
Article Tools
Article Usage
- Total views: 2285
- [From(publication date): 0-2021 - Jul 18, 2025]
- Breakdown by view type
- HTML page views: 1498
- PDF downloads: 787